virus covid-19 vaccine Coronavirus

Covid-19 pandemic: how modelling can support drug development

Reading now: 618
www.pharmaceutical-technology.com

The first of the National Institute of Allergy and Infectious Diseases’ (NIAID) Covid-19 research priorities is to improve understanding of the disease and the novel coronavirus that causes it, SARS-CoV-2.

This helps with understanding the transmission of the disease, including determining whether it is likely to be seasonally circulating, as well as why Covid-19 so dramatically affects some individuals, while others remain asymptomatic.

But better knowledge about the virus and the disease can also support the identification of new drug targets or which existing drugs could help tackle this viral disease.

Drugs are essential to stopping more suffering at the hands of Covid-19; at the time of writing, more than 206,000 people have

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA